rs137852815
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001367721.1(CASK):c.1915C>T(p.Arg639*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001367721.1 stop_gained
Scores
Clinical Significance
Conservation
Publications
- FG syndrome 4Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- syndromic X-linked intellectual disability Najm typeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- X-linked syndromic intellectual disabilityInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CASK | NM_001367721.1 | c.1915C>T | p.Arg639* | stop_gained | Exon 21 of 27 | ENST00000378163.7 | NP_001354650.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CASK | ENST00000378163.7 | c.1915C>T | p.Arg639* | stop_gained | Exon 21 of 27 | 5 | NM_001367721.1 | ENSP00000367405.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Syndromic X-linked intellectual disability Najm type Pathogenic:2
- -
The hemizygous p.Arg639Ter variant in CASK was identified by our study in 1 individual with mental retardation and microcephaly with pontine and cerebellar hypoplasia. Trio exome analysis showed this variant to be de novo. The variant has been reported in 1 Turkish individual with mental retardation and microcephaly with pontine and cerebellar hypoplasia (PMID: 19165920), but was absent from large population studies. This variant has been reported in ClinVar (Variation ID: 11530) as pathogenic by OMIM and GeneDx. This nonsense variant leads to a premature termination codon at position 639, which is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the CASK gene is an established disease mechanism in mental retardation and microcephaly with pontine and cerebellar hypoplasia. In summary, this variant meets criteria to be classified as pathogenic for mental retardation and microcephaly with pontine and cerebellar hypoplasia in an X-linked dominant manner based on the predicted impact of the variant, and occurrences in affected individuals while absent from control populations. ACMG/AMP Criteria applied: PVS1, PM2, PS4_supporting, PS2 (Richards 2015). -
not provided Pathogenic:1
Not observed in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 36703223, 33057194, 35982159, 25525159, 29691940, 19165920, 35670744) -
Intellectual disability Pathogenic:1
PVS1, PS2, PM2 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at